» Articles » PMID: 20173385

Cellular Mechanisms of TNF Function in Models of Inflammation and Autoimmunity

Overview
Publisher Karger
Date 2010 Feb 23
PMID 20173385
Citations 70
Authors
Affiliations
Soon will be listed here.
Abstract

The TNF/TNF receptor (TNFR) system has a prominent role in the pathogenesis of chronic inflammatory and autoimmune disorders. Extensive research in animal models with deregulated TNF expression has documented that TNF may initiate or sustain inflammatory pathology, while at the same time may exert immunomodulatory or disease-suppressive activities. The TNF/TNFR system encompassing both the soluble and the transmembrane form of TNF with differential biological activities, as well as the differential usage of its receptors, mediating distinct functions, appears to confer complexity but also specificity in the action of TNF. The inherent complexity in TNF-mediated pathophysiology highlights the requirement to address the role of TNF taking into account both proinflammatory tissue-damaging and immunomodulatory functions in a cellular and receptor-specific manner. In this review, we discuss our current understanding of the involvement of TNF in chronic inflammation and autoimmunity, focusing on TNF-mediated cellular pathways leading to the pathogenesis or progression of joint and intestinal inflammatory pathology. Knowledge of the mechanisms by which TNF either initiates or contributes to disease pathology is fundamentally required for the design of safe and effective anti-TNF/TNFR therapies for human inflammatory and autoimmune disorders.

Citing Articles

Ileal inflammation is reduced due to treatment with a metalloprotease from BmooMP-α-I snake venom in an experimental model of Toxoplasma gondii infection.

Silva T, Lopes C, Silva M, Ferreira F, Barros H, Ferreira Silva M Parasitol Res. 2023; 123(1):65.

PMID: 38133827 DOI: 10.1007/s00436-023-08033-9.


A Scoping Review on Biomarkers of Endothelial Dysfunction in Small Vessel Disease: Molecular Insights from Human Studies.

Garcia D, Chagnot A, Wardlaw J, Montagne A Int J Mol Sci. 2023; 24(17).

PMID: 37685924 PMC: 10488088. DOI: 10.3390/ijms241713114.


Short Peptides of Innate Immunity Protein Tag7 (PGLYRP1) Selectively Induce Inhibition or Activation of Tumor Cell Death via TNF Receptor.

Yurkina D, Sharapova T, Romanova E, Yashin D, Sashchenko L Int J Mol Sci. 2023; 24(14).

PMID: 37511122 PMC: 10379010. DOI: 10.3390/ijms241411363.


The TNFR1 antagonist Atrosimab reduces neuronal loss, glial activation and memory deficits in an acute mouse model of neurodegeneration.

Orti-Casan N, Boerema A, Kopke K, Ebskamp A, Keijser J, Zhang Y Sci Rep. 2023; 13(1):10622.

PMID: 37391534 PMC: 10313728. DOI: 10.1038/s41598-023-36846-2.


Infliximab Inhibits Colitis Associated Cancer in Model Mice by Downregulating Genes Associated with Mast Cells and Decreasing Their Accumulation.

Wang D, Ohnuma S, Suzuki H, Ishida M, Ishii K, Hirosawa T Curr Issues Mol Biol. 2023; 45(4):2895-2907.

PMID: 37185713 PMC: 10136890. DOI: 10.3390/cimb45040189.